TNF and neoplasm: Thus, these results suggest that CAFs and TNF‐⍺ signaling play a prominent role in the CMS4 subgroup of PM‐CRC, modulating the tumor cells into a mesenchymal‐like phenotype to facilitate intraperitoneal spread, as well as creating an immunosuppressive and chemotherapy‐resistant TME (Figure 5).